Cargando…

C9orf72 and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years

The 2011 discovery of the pathogenic hexanucleotide repeat expansion (HRE) in C9orf72, the leading genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), marked a breakthrough in the effort to unravel the etiology of these conditions. Ten years later, clinicians...

Descripción completa

Detalles Bibliográficos
Autor principal: Roggenbuck, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862089/
https://www.ncbi.nlm.nih.gov/pubmed/33575483
http://dx.doi.org/10.1212/NXG.0000000000000542